Richard Dugan

Direktor/Vorstandsmitglied bei VANDA PHARMACEUTICALS INC.

Vermögen: 604 150 $ am 31.05.2024

82 Jahre

100 Beziehungen

Health Technology

Consumer Services

Commercial Services

Aktive Positionen von Richard Dugan

Unternehmen	Position	Beginn	Ende
VANDA PHARMACEUTICALS INC.	Direktor/Vorstandsmitglied	01.12.2005	-
VANDA PHARMACEUTICALS INC.	Independent Dir/Board Member	01.12.2005	-

Karriereverlauf von Richard Dugan

Ehemalige bekannte Positionen von Richard Dugan

Unternehmen	Position	Beginn	Ende
Middlebrook Pharmaceuticals, Inc. Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MiddleBrook Pharmaceuticals, Inc. develops and commercializes anti-infective drug products. It operates mainly in prescription pharmaceuticals. MiddleBrook's main product is PULSYS. PULSYS technology offers the prolonged release and absorption of a drug. The company was incorporated in December 1999 and is headquartered in Westlake, TX.	Direktor/Vorstandsmitglied	01.09.2003	03.08.2010
Critical Therapeutics, Inc.	Direktor/Vorstandsmitglied	01.04.2004	04.11.2008
Ernst & Young LLP Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY.	Corporate Officer/Principal	01.01.1976	01.09.2002
Antisoma, Inc. Antisoma, Inc. Pharmaceuticals: MajorHealth Technology Antisoma, Inc. develops drugs and pharmaceuticals. The firm's products include Xanafide, Symadex, and Clomet. Its products are used in clinical and preclinical development for multiple cancer indications. The company was founded in 2001 and is headquartered Cambridge, MA.	Direktor/Vorstandsmitglied	01.12.2005	-

Ausbildung von Richard Dugan

The Pennsylvania State University

Undergraduate Degree

Statistik

International

Vereinigte Staaten

Operativ

Director/Board Member	4
Undergraduate Degree	1
Corporate Officer/Principal	1

Sektoral

Health Technology	5
Consumer Services	2
Commercial Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Unternehmensverbindungen

Börsennotierte Unternehmen	1
VANDA PHARMACEUTICALS INC.	Health Technology

Private Unternehmen	4
Critical Therapeutics, Inc.	Health Technology
Middlebrook Pharmaceuticals, Inc. Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MiddleBrook Pharmaceuticals, Inc. develops and commercializes anti-infective drug products. It operates mainly in prescription pharmaceuticals. MiddleBrook's main product is PULSYS. PULSYS technology offers the prolonged release and absorption of a drug. The company was incorporated in December 1999 and is headquartered in Westlake, TX.	Health Technology
Antisoma, Inc. Antisoma, Inc. Pharmaceuticals: MajorHealth Technology Antisoma, Inc. develops drugs and pharmaceuticals. The firm's products include Xanafide, Symadex, and Clomet. Its products are used in clinical and preclinical development for multiple cancer indications. The company was founded in 2001 and is headquartered Cambridge, MA.	Health Technology
Ernst & Young LLP Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY.	Commercial Services

Sehen Sie sich die Unternehmensverbindungen an